July 14, 2011
MichBio was instrumental in forming the State Biosciences Legislative Caucus (BLC) that serves to educate legislators on biotechnology issues. In so doing, we believe that we can ultimately impact policies and programs to benefit the state’s biosciences industry and help make Michigan a leader in this market sector. The BLC is a bipartisan, bicameral body whose membership is open to any interested legislators.
July 14, 2011
MichBio leads advocacy efforts on behalf of the biosciences community, representing members’ interests on critical issues at the local, state and federal levels. In addition, through its affiliation with the Biotechnology Industry Organization (BIO), MichBio regularly attends BIO-organized efforts to positively impact key votes on biotechnology-related legislation.
July 14, 2011
MichBio leads advocacy efforts on behalf of the biosciences community, representing members’ interests on critical issues at the local, state and federal levels. In addition, through its affiliation with the Biotechnology Industry Organization (BIO), MichBio regularly attends BIO-organized efforts to positively impact key votes on biotechnology-related legislation.
July 14, 2011
During the seven years ending in 2008, the research, testing and medical laboratories subsector in Michigan grew faster than the national average, as did employment in agricultural feedstock and chemicals. Total academic bioscience research expenditures in the State were $951 million in 2008, mainly in medical and biological sciences. In the last six years, bioscience venture capital investments had risen steadily to a peak of $138 million in 2008 before falling off as the national sector did in VC funding in 2008. The six‐year cumulative venture funding total for Michigan was $440 million.
July 14, 2011
Speaking to a crowd of more than 160 bioscience leaders at the MichBio Annual Meeting in Ann Arbor Wednesday night, Stephen Rapundalo, Ph.D., MichBio president and CEO, said that a growing awareness by state legislators of the industry’s economic growth potential has culminated in the formation a standing Senate Subcommittee on Bioscience Technologies.
July 14, 2011
Speaking to a crowd of more than 160 bioscience leaders at the MichBio Annual Meeting in Ann Arbor Wednesday night, Stephen Rapundalo, Ph.D., MichBio president and CEO, said that a growing awareness by state legislators of the industry’s economic growth potential has culminated in the formation a standing Senate Subcommittee on Bioscience Technologies.
July 13, 2011
Bio Nebraska Life Sciences Association
Nebraska Department of Health and Human Services
Nebraska Medical Association
Nebraska State Legislature
Nebraska State Senate
Office of Governor Dave Heineman
University of Nebraska-Lincoln – Center for Biotechnology
July 13, 2011
Nebraska’s bioscience industry has a specialized employment concentration and is growing. The state has employment specializations in two of the four major subsectors – agricultural feedstock and chemicals and medical devices and equipment. Academic bioscience research and development expenditures totaled $251 million in 2008, led by biological sciences ($114 million) followed by medical sciences ($70 million) and agricultural sciences ($57 million).
